Mouse TP63(Tumor Protein P63) ELISA Kit
To Order Contact us: Mark@operatiebrp.nl
 ELISA Kit) Human Tumor Protein P63 (TP63) ELISA Kit |
|
RD-TP63-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 625.2 |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
RD-TP63-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 867.6 |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
RDR-TP63-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 652.8 |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
RDR-TP63-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 907.2 |
 ELISA Kit) Mouse Tumor Protein P63 (TP63) ELISA Kit |
|
20-abx154822 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Mu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5834.88 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Mu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 585.7 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Mu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 785.28 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Mu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3173.76 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Tumor Protein P63 (TP63) in Tissue homogenates and other biological fluids. |
Mouse Tumor Protein P63 (TP63) ELISA Kit |
|
4-SEC805Mu |
Cloud-Clone |
-
EUR 5895.60
-
EUR 3114.00
-
EUR 786.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Tumor Protein P63 (TP63) in samples from Tissue homogenates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
 ELISA Kit) Tumor Protein P63 (TP63) ELISA Kit |
|
abx595451-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
|
Tumor Protein P63 (TP63) ELISA Kit |
|
abx596528-96tests |
Abbexa |
96 tests |
EUR 867.6 |
|
|
 Protein) Mouse Tumor Protein P63 (TP63) Protein |
|
20-abx655396 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Mouse Tumor Protein P63 (TP63) Protein |
|
20-abx655397 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
) ELISA kit for Mouse TP63 (Tumor Protein P63) |
|
ELK6941 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Tumor Protein P63 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
 CLIA Kit) Mouse Tumor Protein P63 (TP63) CLIA Kit |
|
20-abx493910 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 ELISA Kit) Human TP63(Tumor Protein p63) ELISA Kit |
|
EH3899 |
FN Test |
96T |
EUR 628.92 |
|
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
20-abx153410 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 ELISA Kit) Chicken Tumor Protein p63 (TP63) ELISA Kit |
|
abx355784-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Rabbit Tumor Protein p63 (TP63) ELISA Kit |
|
abx363814-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Sheep Tumor Protein p63 (TP63) ELISA Kit |
|
abx364237-96tests |
Abbexa |
96 tests |
EUR 1111.2 |
|
|
 ELISA Kit) Monkey Tumor Protein p63 (TP63) ELISA Kit |
|
abx358943-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Pig Tumor Protein p63 (TP63) ELISA Kit |
|
abx360811-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Human Tumor Protein p63 (TP63) ELISA Kit |
|
abx253299-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
Human Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5677.8 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 572.76 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 766.8 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
SEC805Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3090.6 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Tumor Protein P63 (TP63) in Tissue homogenates, cell lysates and other biological fluids. |
Human Tumor Protein P63 (TP63) ELISA Kit |
|
4-SEC805Hu |
Cloud-Clone |
-
EUR 5738.40
-
EUR 3031.20
-
EUR 768.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Tumor Protein P63 (TP63) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
 Antibody) Tumor Protein P63 (TP63) Antibody |
|
20-abx174991 |
Abbexa |
-
EUR 526.80
-
EUR 1378.80
-
EUR 678.00
-
EUR 184.80
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx124012 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx116376 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx001749 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx013168 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
abx027712-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Tumor Protein P63 (TP63) Antibody |
|
abx027712-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Tumor Protein P63 (TP63) Antibody |
|
abx025498-100ul |
Abbexa |
100 ul |
EUR 627.6 |
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx330063 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
abx332261-100ul |
Abbexa |
100 ul |
EUR 510 |
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx327716 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx178773 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx178774 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx178775 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx214758 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
20-abx214076 |
Abbexa |
|
|
|
|
Tumor Protein P63 (TP63) Antibody |
|
abx238880-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
|
 Protein) Human Tumor Protein P63 (TP63) Protein |
|
20-abx655395 |
Abbexa |
-
EUR 610.80
-
EUR 292.80
-
EUR 1746.00
-
EUR 710.40
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
) ELISA kit for Human TP63 (Tumor Protein p63) |
|
E-EL-H2304 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
|
|
Description: A sandwich ELISA kit for quantitative measurement of Human TP63 (Tumor Protein p63) in samples from Serum, Plasma, Cell supernatant |
) ELISA kit for Human TP63 (Tumor Protein P63) |
|
ELK3138 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Tumor Protein P63 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
 CLIA Kit) Human Tumor Protein p63 (TP63) CLIA Kit |
|
abx197863-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 CLIA Kit) Human Tumor Protein P63 (TP63) CLIA Kit |
|
20-abx493909 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
) OVA Conjugated Tumor Protein P63 (TP63) |
|
4-CPC805Hu21 |
Cloud-Clone |
-
EUR 259.78
-
EUR 193.20
-
EUR 644.16
-
EUR 294.72
-
EUR 469.44
-
EUR 249.60
-
EUR 1430.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Tumor Protein P63 expressed in: chemical synthesis |
 Protein (OVA)) Human Tumor Protein P63 (TP63) Protein (OVA) |
|
20-abx651274 |
Abbexa |
-
EUR 360.00
-
EUR 243.60
-
EUR 895.20
-
EUR 410.40
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
) CLIA kit for Human TP63 (Tumor Protein p63) |
|
E-CL-H1352 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
|
|
Description: A sandwich CLIA kit for quantitative measurement of Human TP63 (Tumor Protein p63) in samples from Serum, Plasma, Cell supernatant |
 Monoclonal Antibody (Human)) Tumor Protein P63 (TP63) Monoclonal Antibody (Human) |
|
4-MAC805Hu22 |
Cloud-Clone |
-
EUR 306.00
-
EUR 3170.40
-
EUR 786.00
-
EUR 386.40
-
EUR 260.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63) |
 Polyclonal Antibody (Human)) Tumor Protein P63 (TP63) Polyclonal Antibody (Human) |
|
4-PAC805Hu01 |
Cloud-Clone |
-
EUR 296.40
-
EUR 3012.00
-
EUR 750.00
-
EUR 372.00
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63) |
 Antibody) Tumor Protein P63 Phospho-Ser395 (TP63 pS395) Antibody |
|
20-abx012715 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
Tumor Protein P63 Phospho-Ser395 (TP63 pS395) Antibody |
|
abx333541-100ul |
Abbexa |
100 ul |
EUR 560.4 |
|
|
 Antibody) Tumor Protein P63 Phospho-Ser455 (TP63 pS455) Antibody |
|
20-abx324486 |
Abbexa |
|
|
|
|
Tumor Protein P63 Phospho-Ser395 (TP63 pS395) Antibody |
|
20-abx327760 |
Abbexa |
|
|
|
|
 Monoclonal Antibody (Human), APC) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), APC |
|
4-MAC805Hu22-APC |
Cloud-Clone |
-
EUR 429.60
-
EUR 4146.00
-
EUR 1148.40
-
EUR 549.60
-
EUR 268.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC. |
 Monoclonal Antibody (Human), Biotinylated) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), Biotinylated |
|
4-MAC805Hu22-Biotin |
Cloud-Clone |
-
EUR 384.00
-
EUR 3110.40
-
EUR 912.00
-
EUR 472.80
-
EUR 267.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Biotin. |
 Monoclonal Antibody (Human), Cy3) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), Cy3 |
|
4-MAC805Hu22-Cy3 |
Cloud-Clone |
-
EUR 522.00
-
EUR 5478.00
-
EUR 1482.00
-
EUR 682.80
-
EUR 309.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Cy3. |
 Monoclonal Antibody (Human), FITC) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), FITC |
|
4-MAC805Hu22-FITC |
Cloud-Clone |
-
EUR 367.20
-
EUR 3340.80
-
EUR 943.20
-
EUR 463.20
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with FITC. |
 Monoclonal Antibody (Human), HRP) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), HRP |
|
4-MAC805Hu22-HRP |
Cloud-Clone |
-
EUR 392.40
-
EUR 3613.20
-
EUR 1015.20
-
EUR 495.60
-
EUR 253.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with HRP. |
 Monoclonal Antibody (Human), PE) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), PE |
|
4-MAC805Hu22-PE |
Cloud-Clone |
-
EUR 367.20
-
EUR 3340.80
-
EUR 943.20
-
EUR 463.20
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with PE. |
 Polyclonal Antibody (Human), APC) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), APC |
|
4-PAC805Hu01-APC |
Cloud-Clone |
-
EUR 414.00
-
EUR 3930.00
-
EUR 1094.40
-
EUR 528.00
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC. |
 Polyclonal Antibody (Human), Biotinylated) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), Biotinylated |
|
4-PAC805Hu01-Biotin |
Cloud-Clone |
-
EUR 373.20
-
EUR 2952.00
-
EUR 872.40
-
EUR 457.20
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Biotin. |
 Polyclonal Antibody (Human), Cy3) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), Cy3 |
|
4-PAC805Hu01-Cy3 |
Cloud-Clone |
-
EUR 502.80
-
EUR 5190.00
-
EUR 1410.00
-
EUR 654.00
-
EUR 301.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with Cy3. |
 Polyclonal Antibody (Human), FITC) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), FITC |
|
4-PAC805Hu01-FITC |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with FITC. |
 Polyclonal Antibody (Human), HRP) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), HRP |
|
4-PAC805Hu01-HRP |
Cloud-Clone |
-
EUR 379.20
-
EUR 3426.00
-
EUR 968.40
-
EUR 477.60
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with HRP. |
 Polyclonal Antibody (Human), PE) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), PE |
|
4-PAC805Hu01-PE |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with PE. |
 Anti-p63/TP63 |
|
DB-133-0.05 |
DB Biotech |
50 μl |
EUR 352.8 |
Anti-p63/TP63 |
|
DB-133-0.1 |
DB Biotech |
100 μl |
EUR 555.6 |
 Mouse Tumor Protein P63 ELISA kit |
|
E03T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Mouse Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Tumor Protein P63 ELISA kit |
|
E03T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Mouse Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Tumor Protein P63 ELISA kit |
|
E03T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Mouse Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
) p63 (Tumor Protein p63) |
|
MO47058 |
Neuromics |
100 ul |
EUR 418.8 |
 Monoclonal Antibody (Human), APC-Cy7) Tumor Protein P63 (TP63) Monoclonal Antibody (Human), APC-Cy7 |
|
4-MAC805Hu22-APC-Cy7 |
Cloud-Clone |
-
EUR 715.20
-
EUR 8148.00
-
EUR 2154.00
-
EUR 955.20
-
EUR 394.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC-Cy7. |
 Polyclonal Antibody (Human), APC-Cy7) Tumor Protein P63 (TP63) Polyclonal Antibody (Human), APC-Cy7 |
|
4-PAC805Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 685.20
-
EUR 7716.00
-
EUR 2046.00
-
EUR 912.00
-
EUR 382.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Tumor Protein P63 (TP63). This antibody is labeled with APC-Cy7. |
 Anti-p63/TP63 Antibody |
|
PA2056 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-p63/TP63 Antibody |
|
PB9152 |
BosterBio |
100ug/vial |
EUR 400.8 |
 Human Tumor Protein P63 ELISA kit |
|
E01T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Tumor Protein P63 ELISA kit |
|
E01T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Tumor Protein P63 ELISA kit |
|
E01T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Rabbit Tumor Protein P63 ELISA kit |
|
E04T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Rabbit Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Tumor Protein P63 ELISA kit |
|
E04T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Rabbit Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Tumor Protein P63 ELISA kit |
|
E04T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Rabbit Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Goat Tumor Protein P63 ELISA kit |
|
E06T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Goat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Tumor Protein P63 ELISA kit |
|
E06T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Goat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Tumor Protein P63 ELISA kit |
|
E06T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Goat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Dog Tumor Protein P63 ELISA kit |
|
E08T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Canine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Tumor Protein P63 ELISA kit |
|
E08T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Canine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Tumor Protein P63 ELISA kit |
|
E08T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Canine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Pig Tumor Protein P63 ELISA kit |
|
E07T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Porcine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Tumor Protein P63 ELISA kit |
|
E07T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Porcine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Tumor Protein P63 ELISA kit |
|
E07T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Porcine Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Rat Tumor Protein P63 ELISA kit |
|
E02T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Rat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Tumor Protein P63 ELISA kit |
|
E02T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Rat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Tumor Protein P63 ELISA kit |
|
E02T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Rat Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Monkey Tumor Protein P63 ELISA kit |
|
E09T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Monkey Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Tumor Protein P63 ELISA kit |
|
E09T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Monkey Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Tumor Protein P63 ELISA kit |
|
E09T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Monkey Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 Guinea pig Tumor Protein P63 ELISA kit |
|
E05T0290-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Tumor Protein P63 ELISA kit |
|
E05T0290-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Tumor Protein P63 ELISA kit |
|
E05T0290-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Tumor Protein P63 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
) ELISA kit for Human Tumor protein 63 (TP63) |
|
KTE60153-48T |
Abbkine |
48T |
EUR 398.4 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Tumor protein 63 (TP63) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Tumor protein 63 (TP63) |
|
KTE60153-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Tumor protein 63 (TP63) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Tumor protein 63 (TP63) |
|
KTE60153-96T |
Abbkine |
96T |
EUR 646.8 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Tumor protein 63 (TP63) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
) Human Tumor protein 63 (TP63) |
|
1-CSB-RP116694h |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Tumor protein 63(TP63) expressed in E.coli |
 p63 Antibody / Tumor protein 63 |
|
V3367-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3367-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3367SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3368-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3368-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3368SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3815-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3815-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3815SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3816-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. [UniProt] |
p63 Antibody / Tumor protein 63 |
|
V3816-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. [UniProt] |
p63 Antibody / Tumor protein 63 |
|
V3816SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. Isoform 2 activates RIPK4 transcription. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. Involved in Notch signaling by probably inducing JAG1 and JAG2. Plays a role in the regulation of epithelial morphogenesis. The ratio of DeltaN-type and TA*-type isoforms may govern the maintenance of epithelial stem cell compartments and regulate the initiation of epithelial stratification from the undifferentiated embryonal ectoderm. Required for limb formation from the apical ectodermal ridge. Activates transcription of the p21 promoter. [UniProt] |
p63 Antibody / Tumor protein 63 |
|
V3947-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3947-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3947SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3948-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3948-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V3948SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V7466-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V7466-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V7466IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V7466SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9353-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9353-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9353SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9374-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9374-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9374SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9376-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9376-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
p63 Antibody / Tumor protein 63 |
|
V9376SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands; however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90%. Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80%. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. |
 Recombinant Human P63/ TP63 Protein, His, E.coli-100ug |
|
QP8724-ec-100ug |
EnQuireBio |
100ug |
EUR 489.6 |
 Recombinant Human P63/ TP63 Protein, His, E.coli-10ug |
|
QP8724-ec-10ug |
EnQuireBio |
10ug |
EUR 240 |
 Recombinant Human P63/ TP63 Protein, His, E.coli-1mg |
|
QP8724-ec-1mg |
EnQuireBio |
1mg |
EUR 1958.4 |
 Recombinant Human P63/ TP63 Protein, His, E.coli-200ug |
|
QP8724-ec-200ug |
EnQuireBio |
200ug |
EUR 760.8 |
 Recombinant Human P63/ TP63 Protein, His, E.coli-500ug |
|
QP8724-ec-500ug |
EnQuireBio |
500ug |
EUR 1272 |
 Recombinant Human P63/ TP63 Protein, His, E.coli-50ug |
|
QP8724-ec-50ug |
EnQuireBio |
50ug |
EUR 315.6 |
 Mouse TP63 ELISA Kit |
|
EMT0297 |
Abclonal |
96Tests |
EUR 625.2 |
 Anti-p63 Antibody Clone TP63/1786, Unconjugated-20ug |
|
8626-MSM6-P0 |
EnQuireBio |
20ug |
EUR 279.6 |
 Anti-p63 Antibody Clone TP63/1786, Unconjugated-100ug |
|
8626-MSM6-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
 ELISA Kit, 96 tests, Quantitative) Human Tumor Protein 63 (P63) ELISA Kit, 96 tests, Quantitative |
|
9645 |
Alpha Diagnostics |
1 Kit |
EUR 927.6 |
 (OKDD00810)) TP63 ELISA Kit (Mouse) (OKDD00810) |
|
OKDD00810 |
Aviva Systems Biology |
96 Wells |
EUR 1185.6 |
|
Description: Description of target: This gene encodes tumor protein p63, a member of the p53 family of transcription factors involved in cellular responses to stress and development. the family members include tumor proteins p53, p63, and p73, which have high sequence similarity to one another. this similarity allows p63 and p73 to transactivate p53-responsive genes causing cell cycle arrest and apoptosis. the family members can interact with each other in many ways, including direct and indirect protein interactions. this results in mutual regulation of target gene promoters. tumor protein p63 -/- mice have several developmental defects which include the lack of limbs and other tissues, such as teeth and mammary glands, which develop as a result of interactions between mesenchyme and epithelium. both alternative splicing and the use of alternative promoters result in multiple transcript variants encoding different protein isoforms.;Species reactivity: Mouse;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: <0.054ng/mL |
 (TP63/2427) Antibody) p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC942427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF594 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC942427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF594 conjugate, Concentration: 0.1mg/mL |
 (TP63/2428) Antibody) p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC942428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF594 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC942428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF594 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCA2427-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), APC conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCA2428-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), APC conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC552427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF555 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC552427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF555 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC552428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF555 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC552428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF555 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC612427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF660R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC612427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF660R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC612428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF660R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC612428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF660R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCP2427-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), PerCP conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCP2428-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), PerCP conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCR2427-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), RPE conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCR2428-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), RPE conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC402427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF640R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC402427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF640R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC402428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF640R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC402428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF640R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC432427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF543 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC432427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF543 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC432428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF543 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC432428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF543 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC052427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405M conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC052427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405M conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC052428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405M conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC052428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405M conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC812427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC812427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC812428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC812428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680R conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC802427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC802427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF680 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC802428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC802428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF680 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCH2427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCH2427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCH2428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCH2428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNUB2427-100 |
Biotium |
100uL |
EUR 316.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Concentration: 0.2mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNUB2427-50 |
Biotium |
50uL |
EUR 486 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), 1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNUB2427-500 |
Biotium |
500uL |
EUR 615.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Concentration: 0.2mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNUB2428-100 |
Biotium |
100uL |
EUR 316.8 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Concentration: 0.2mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNUB2428-50 |
Biotium |
50uL |
EUR 486 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), 1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNUB2428-500 |
Biotium |
500uL |
EUR 615.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Concentration: 0.2mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC042427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405S conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC042427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF405S conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC042428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405S conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC042428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF405S conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC682427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF568 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC682427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF568 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC682428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF568 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC682428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF568 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC702427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF770 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC702427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF770 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC702428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF770 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC702428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF770 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCAP2427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCAP2427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCAP2428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNCAP2428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC882427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF488A conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC882427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF488A conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC882428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF488A conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC882428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF488A conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC472427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF647 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNC472427-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), CF647 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC472428-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF647 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2428) Antibody |
|
BNC472428-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF647 conjugate, Concentration: 0.1mg/mL |
p63 (Squamous Basal & Myoepithelial Cell Marker) (TP63/2427) Antibody |
|
BNCB2427-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against p63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2427), Biotin conjugate, Concentration: 0.1mg/mL |
